Dr. Stephen Matta, DO, MBA, CAQSM, is a triple board-certified physician in Family Medicine, Sports Medicine, and Stem Cell Therapy. He is co-founder of Meeting Point Health in Philadelphia. Specializing in regenerative orthopedics, anti-aging, and cellular medicine, he integrates holistic therapies like ultrasound-guided regenerative injections with orthobiologics, osteopathic manipulation, peptide and hormone therapy, and medical acupuncture to address chronic pain and nervous system dysregulation. A graduate of Philadelphia College of Osteopathic Medicine, Dr. Matta completed his residency at Valley Baptist Family Practice in Texas, and a fellowship in Primary Care Sports Medicine at Mountainside Sports Medicine in New Jersey. His East-meets-West approach, co-developed with his wife, Mary Anne Matta, emphasizes root-cause solutions, utilizing peptides, ozone therapy, and stem cell therapy. Formerly a team physician for the Antigua Professional Soccer Team and NJIT Division I sports, Dr. Matta is a Fellow of the SSRP Institute and a sought-after speaker. His comprehensive assessments and patient-centered care have transformed lives, earning him a reputation as a master diagnostician dedicated to unlocking human potential through integrative medicine.
Article
Dec 10, 2025
Stephen Matta, DO, MBA, CAQSM
Myriah Werne
RELATED RESOURCES
Continue exploring related topics.
VIEW ALL
SSRP Institute
Jun 10, 2026
PCOS Name Change to PMOS: Polyendocrine Metabolic Ovarian Syndrome
HEADLINE SCIENCE An international body of medical scientists, obstetrics and gynecology, endocrinology, and other speciality societies, and other physicians announced the result of a multi-year process to formerly change the name of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change, published in May 2026 in The Lancet, aims to address the […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Jun 8, 2026
Ep. 091 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 091
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)
Preview Only — Become a member for full access
William Seeds, MD
Jun 3, 2026
GLP-1 and the Gut–Musculoskeletal Axis: A Clinical Summary
The Overlooked Connection: Dysbiosis and Degenerative Disease Degenerative musculoskeletal diseases, including osteoarthritis (OA), osteoporosis (OP), sarcopenia (SP), and intervertebral disc degeneration (IVDD), affect well over a billion people globally and share three core pathological features: chronic inflammation, oxidative stress, and dysregulated cell death. What is increasingly clear, and clinically underappreciated, is that gut microbiota (GM) […]
READ ARTICLE
Certification
Peptide Therapy Certification 2026
Clinical peptides are proving to be an increasingly impactful tool in a physician’s patient care toolkit. With wide-ranging applicability across cardiology, pediatrics, fertility, orthopaedics, and more, peptide therapy can help you deliver more individualized care and create better outcomes for...
REGISTER NOW
VIDEO
Cellular Medicine Mondays
Jun 1, 2026
Ep. 090 - Dr. Seeds’ Office Hours - Bonus Episode
Preview Only
Dr. Seeds’ Office Hours – Episode 090
In this bonus episode from the MM15 Virtual Summit, Dr. Seeds addresses an important question around the use of GLP-1s for metabolic balancing in patients who do not need to lose weight. He shares his perspective on what may be considered microdosing, along with the clinical thought process he uses when determining appropriate dosing in these more nuanced cases.
Additional questions from the MM15 Virtual Summit can be found in our accompanying article here: [insert article link]
Access the full MM15 Course here: Mastermind 15 on Aesthetics
Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
May 25, 2026
Ep. 089 - The Limits of Alternative Peptide Delivery
Preview Only
Dissecting Protocols – Episode 089
The Limits of Alternative Peptide Delivery
Dr. Seeds reviews oral, sublingual, and transdermal peptide delivery, and explains why subcutaneous injection remains the gold standard for most peptides. (Question Link)
Preview Only — Become a member for full access
GuardianMD
May 21, 2026
SSRP Institute Welcomes GuardianMD as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [May 21, 2026] — The SSRP Institute announces that GuardianMD has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. GuardianMD is a healthcare services organization focused on physician collaboration and medical direction. It also provides telemedicine clearance services for healthcare practices. The company supports […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 18, 2026
Ep. 088 - A Deeper Look at the RAAS System
Preview Only
Rabbit Holes – Episode 088
A Deeper Look at the RAAS System
Dr. Seeds uses this Rabbit Holes episode to build on Journal Club Episode 87, revisiting the renin-angiotensin-aldosterone system and its broader role in cellular signaling. The discussion focuses on receptor balance, local tissue effects, and the mechanisms linking RAS disruption to inflammation, fibrosis, and mitochondrial stress.(Article Link)
Preview Only — Become a member for full access
William Seeds, MD
May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions
In this research article, I return to the subject of my first-ever Journal Club (Ep. 017), in which I discussed a 2023 research study entitled, “Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection” (2023) that examined a specific growth hormone-derived peptide to address the underlying immunological mechanisms of post-viral […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
May 11, 2026
Ep. 087 - The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Preview Only
Journal Club – Episode 087
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Dr. Seeds unpacks how RAS receptor balance drives inflammation, fibrosis, mitochondrial dysfunction, and tissue remodeling, far beyond its classical role in blood pressure regulation. (Article Link)
Preview Only — Become a member for full access